Orfiril (Sodium Valproate)

Sodium Valproate, the active ingredient in Orfiril, is an anticonvulsant presented as a tablet for oral use. It treats epilepsy and related seizure disorders in adults and children. GNH USA supplies Orfiril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Orfiril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orfiril is an antiepileptic drug that is used across several seizure‑related conditions.

- Focal seizures: helps control episodes of focal onset seizures. - Generalized tonic‑clonic seizures: reduces the frequency of generalized tonic‑clonic seizures. - Absence seizures: decreases the number of absence episodes. - Myoclonic seizures: aids in the management of myoclonic seizures. - Lennox‑Gastaut syndrome: used as part of a combination therapy for this severe epilepsy syndrome.

Side effects of            Sodium S  S   S … …  … … … … …  … … … …